Marc Rothenberg, MD, PhD
Director of the Division of Allergy and Immunology
Rothenberg is a tenured professor of pediatrics at Cincinnati Children’s and the University of Cincinnati College of Medicine. He graduated summa cum laude with highest honors in chemistry and biochemistry from Brandeis University. At Harvard Medical School in the combined MD / PhD program, his PhD under the mentorship of Dr. Frank Austen included seminal studies on eosinophil hematopoiesis. He developed the first culture system for human eosinophils. After a two-year residency in pediatrics at Children’s Hospital Boston, Rothenberg did a combined fellowship in allergy / immunology and hematology there. During this fellowship, Rothenberg did postdoctorate training in the genetics laboratory of Dr. Philip Leder at Harvard Medical School, where he cloned the eotaxin chemokine. On faculty of Harvard Medical School for one year, he came to the University of Cincinnati and Cincinnati Children's, where he has helped build a top program in pediatric research, and his division is a leader in pediatric allergy and immunology. He manages a research program focused on understanding the molecular mechanisms of allergic disorders. In addition, he sees patients suffering from allergic and immunological diseases from around the world as part of the Cincinnati Center for Eosinophilic Disorders, which he directs.
Rothenberg’s awards include the Pharmacia Allergy Research Foundation Award for the best young investigator in the allergy field; the Young Investigator Award and the Scholar in Allergy Award from the American Academy of Allergy, Asthma and Immunology; the Ohio Governor’s Recognition Award; the 2007 E. Mead Johnson Award from the Society of Pediatric Research; and an NIH MERIT Award in 2010 from the NIAID. He is an elected member of the American Society of Clinical Investigation, Association of American Physicians, Society for Pediatric Research, and a diplomate of the American Academy of Allergy, Asthma and Immunology. Among his extensive publications of over 250 articles on molecular mechanisms of allergic responses, Rothenberg edited a book, “Chemokines in Allergic Disease.” He has served on various review panels for journals and grant agencies including the National Institutes of Health, where he served on the Advisory Council of the NIAID, Burroughs Trust, and the Medical Research Council of the UK. His research has been supported by numerous sources including the National Institutes of Health, the US Department of Defense, Human Frontier Science Program Organization, the Burroughs Wellcome Fund, the Dana Foundation and the Food Allergy and Anaphylaxis Network.
marc.rothenberg@cchmc.org
